Rapid Micro Biosystems (RPID) Gross Profit (2020 - 2026)

Rapid Micro Biosystems has disclosed Gross Profit across 7 years of filings, most recently posting $1.2 million for Q2 2026.

• In Q2 2026, Gross Profit rose 340.73% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $5.1 million (down 8.68% YoY), while the FY2025 annual figure was $7.6 million, up 8.53% from the prior year.
• Gross Profit came in at $1.2 million for Q2 2026 at Rapid Micro Biosystems, up from $371000.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $2.6 million in Q4 2024 to a low of -$888000.0 in Q3 2022.
• Average Gross Profit over 5 years is $770666.7, with a median of $446000.0 recorded in 2023.
• The largest YoY upside for Gross Profit was 1544.74% in 2022 against a maximum downside of 247.75% in 2022.
• Over 5 years, Gross Profit stood at -$883000.0 in 2022, then soared by 285.5% to $1.6 million in 2023, then jumped by 57.57% to $2.6 million in 2024, then slumped by 53.12% to $1.2 million in 2025, then grew by 0.17% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $1.2 million in Q2 2026, $371000.0 in Q1 2026, and $1.2 million in Q4 2025.